Targeting MMPs in acute and chronic neurological conditions (Q36963155)

17 August 2017

1 reference

title

Targeting MMPs in acute and chronic neurological conditions (English)

1 reference

17 August 2017

V Wee Yong

1

1 reference

17 August 2017

Smriti M Agrawal

series ordinal

2

1 reference

17 August 2017

David P Stirling

series ordinal

3

1 reference

17 August 2017

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

4

1 reference

17 August 2017

580-589

1 reference

https://scigraph.springernature.com/pub.10.1016/j.nurt.2007.07.005

17 August 2017

0 references

cites work

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases as modulators of inflammation and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases and the regulation of tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases: they're not just for matrix anymore!

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Structure and function of matrix metalloproteinases and TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases and diseases of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Regulation of matrix biology by matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Regulation of matrix metalloproteinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

A disintegrin and metalloprotease 21 (ADAM21) is associated with neurogenesis and axonal growth in developing and adult rodent CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

The role of matrix metalloproteinases in the morphogenesis of the cerebellar cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

The function of neurofascin155 in oligodendrocytes is regulated by metalloprotease-mediated cleavage and ectodomain shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Metalloproteinases: mediators of pathology and regeneration in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Role of matrix metalloproteinases in delayed cortical responses after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Multiple roles for MMPs and TIMPs in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Microglial activation and matrix protease generation during focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Inhibition of MMP-dependent chemotaxis and amelioration of experimental autoimmune uveitis with a selective metalloproteinase-2 and -9 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

The role of matrix metalloproteinases in infant traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Towards third generation matrix metalloproteinase inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases as valid clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Inhibition of autoimmune encephalomyelitis by a tetracycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Effect of minocycline in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

The promise of minocycline in neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

ADAM-15/metargidin mediates homotypic aggregation of human T lymphocytes and heterotypic interactions of T lymphocytes with intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Metalloproteases regulate T-cell proliferation and effector function via LAG-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Human Monocyte-Derived Dendritic Cells Produce Bioactive Gelatinase B: Inhibition by IFN-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.005

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

21 January 2018

1 reference

12 December 2020

Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan

1 reference

12 December 2020

Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice

1 reference

12 December 2020

Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

MMPs in the central nervous system: where the good guys go bad.

1 reference

12 December 2020

Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development

1 reference

12 December 2020

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover

1 reference

12 December 2020

An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization.

1 reference

12 December 2020

Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

1 reference

12 December 2020

Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

12 December 2020

Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis

1 reference

12 December 2020

Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets

1 reference

12 December 2020

Matrix metalloproteinases in multiple sclerosis: is it time for a treatment trial?

1 reference

12 December 2020

Metalloproteases and guidance of retinal axons in the developing visual system.

1 reference

12 December 2020

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

12 December 2020

The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice

1 reference

12 December 2020

Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth

1 reference

12 December 2020

An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice

1 reference

12 December 2020

MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization

1 reference

12 December 2020

Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease

1 reference

12 December 2020

Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.

1 reference

12 December 2020

Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.

1 reference

12 December 2020

10.1016/J.NURT.2007.07.005

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

0 references

0 references

1 reference